Chappuis PO - Search Results

1

TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD. Greenblatt MS, et al. Among authors: chappuis po. Cancer Res. 2001 May 15;61(10):4092-7. Cancer Res. 2001. PMID: 11358831

2

Screening for ovarian cancer.

Chappuis PO, Narod SA, Foulkes WD. Chappuis PO, et al. Lancet. 1999 Aug 7;354(9177):509-10. doi: 10.1016/S0140-6736(05)75539-2. Lancet. 1999. PMID: 10465194 Clinical Trial. No abstract available.

3

The influence of familial and hereditary factors on the prognosis of breast cancer.

Chappuis PO, Rosenblatt J, Foulkes WD. Chappuis PO, et al. Ann Oncol. 1999 Oct;10(10):1163-70. doi: 10.1023/a:1008301314812. Ann Oncol. 1999. PMID: 10586331 Free article. Review.

4

Long-term outcome of invasive breast cancer.

Chappuis PO, Deschênes J, Foulkes WD. Chappuis PO, et al. Lancet. 2000 Apr 29;355(9214):1551; author reply 1552-3. doi: 10.1016/S0140-6736(00)02178-4. Lancet. 2000. PMID: 10801192 No abstract available.

5

Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

Chappuis PO, Nethercot V, Foulkes WD. Chappuis PO, et al. Semin Surg Oncol. 2000 Jun;18(4):287-95. doi: 10.1002/(sici)1098-2388(200006)18:4<287::aid-ssu3>3.0.co;2-5. Semin Surg Oncol. 2000. PMID: 10805950

6

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

Foulkes WD, Chappuis PO, Wong N, Brunet JS, Vesprini D, Rozen F, Yuan ZQ, Pollak MN, Kuperstein G, Narod SA, Bégin LR. Foulkes WD, et al. Among authors: chappuis po. Ann Oncol. 2000 Mar;11(3):307-13. doi: 10.1023/a:1008340723974. Ann Oncol. 2000. PMID: 10811497 Free article.

7

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

Chappuis PO, Kapusta L, Bégin LR, Wong N, Brunet JS, Narod SA, Slingerland J, Foulkes WD. Chappuis PO, et al. J Clin Oncol. 2000 Dec 15;18(24):4045-52. doi: 10.1200/JCO.2000.18.24.4045. J Clin Oncol. 2000. PMID: 11118465

8

Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.

Chappuis PO, Hamel N, Paradis AJ, Deschênes J, Tonin PN, Ghadirian P, Foulkes WD. Chappuis PO, et al. J Natl Cancer Inst. 2001 Jan 17;93(2):152-4. doi: 10.1093/jnci/93.2.152-a. J Natl Cancer Inst. 2001. PMID: 11208888 No abstract available.

9

The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update.

Chappuis PO, Ghadirian P, Foulkes WD. Chappuis PO, et al. Cancer Invest. 2001;19(1):65-75. doi: 10.1081/cnv-100000076. Cancer Invest. 2001. PMID: 11291558 Review.

10

Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.

Chappuis PO, Hamel N, Paradis AJ, Deschênes J, Robidoux A, Potvin C, Cantin J, Tonin P, Ghadirian P, Foulkes WD. Chappuis PO, et al. Clin Genet. 2001 Jun;59(6):418-23. doi: 10.1034/j.1399-0004.2001.590606.x. Clin Genet. 2001. PMID: 11453973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters